YERXA BENJAMIN R — SEC Form 4 filings
SEC reporting owner CIK 1145910. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-27.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-15 to 2026-07-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 17,813 shares, $20,069 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 14,899 shares, $61,185 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 7,470 shares @ $5.24 ($39,121) in Opus Genetics, Inc., filed 2026-04-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | President, Director | 6 | 1 leg · 10,000 sh · $9,834 | 2 legs · 14,899 sh · $61,185 | 3 |
| Clearside Biomedical, Inc. (CLSD) | Director | 2 | 1 leg · 7,813 sh · $10,235 | — | 1 |
Form 4 filings — YERXA BENJAMIN R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,429 @ $2.97 | EDGAR |
| 2026-04-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,470 @ $5.24 | EDGAR |
| 2026-01-26 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2025-10-24 | 4 | Opus Genetics, Inc. (IRD) | Tax withholding (F): 23,795 @ $1.95 | EDGAR |
| 2024-11-25 | 4 | Opus Genetics, Inc. (IRD) | Purchase (P): 10,000 @ $0.98 | EDGAR |
| 2024-11-12 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 332,800 @ $0 | EDGAR |
| 2024-06-21 | 4 | Clearside Biomedical, Inc. (CLSD) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | Clearside Biomedical, Inc. (CLSD) | Purchase (P): 7,813 @ $1.31 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1145910 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →